Results of the JAVELIN Gastric 100 phase 3 trial: avelumab maintenance following first-line (1L) chemotherapy (CTx) vs continuation of CTx for HER2-advanced gastric or gastroesophageal junction cancer (GC/GEJC)

Copy For Citation

Moehler M. H., Dvorkin M., Ozguroglu M., Ryu M., Muntean A. S., Lonardi S., ...More

Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, San-Francisco, Costa Rica, 23 - 25 January 2020, vol.38, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 38
• City: San-Francisco
• Country: Costa Rica
• Akdeniz University Affiliated: Yes